Assessment method for prostatic cancer onset risk gene and diagnostic kit
A diagnostic kit and prostate cancer technology, applied in the biological field, can solve the problems of unclear cause of prostate cancer and slow growth of prostate cancer
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0020] The T-G-C-C-T-G haplotype composed of SNP10-11-13-15-22-23 in the OPN gene will significantly increase the risk of prostate cancer (P=3.64×10 -6 ), the G-T-C-C-T-G haplotype will significantly reduce the risk of prostate cancer (P=0.0185).
[0021] Individuals with the G-T-C-A-A haplotype composed of SNP35-49-59-62-64 in the OPN gene will significantly reduce the risk of prostate cancer (P=0.0069).
[0022] SNP35-49-59 in the OPN gene constitutes the A-C-T haplotype, the incidence of prostate cancer is significantly increased (P=0.002), and the probability of prostate hyperplasia is increased in the G-T-C haplotype (P=0.002).
[0023]
[0024]
[0025]
[0026]
[0027]
[0028]
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com